The Economist discusses this question:
But human kidneys are no ordinary commodity. Trading them is banned in most countries. So supply depends largely on the charity of individuals: some are willing to donate one of their healthy kidneys while they are still alive (at very little risk to their health); others agree to let their kidneys be used when they die. Unsurprisingly, with altruism the only incentive, not enough people offer.










![Clinicians are failing at value-based care because no one taught them the system [PODCAST]](https://kevinmd.com/wp-content/uploads/bd31ce43-6fb7-4665-a30e-ee0a6b592f4c-190x100.jpeg)






